Ceapro Inc. to Present at the Fall Investor Summit in New York
Presentation with live audio webcast Monday, September 16th at 2:30 PM EDT
EDMONTON, Alberta, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced that Gilles Gagnon, M.Sc., MBA, President and CEO of Ceapro, will present at the Fall Investor Summit on Monday, September 16, 2019 at 2:30 PM EDT in New York, NY.
In addition to the presentation, Mr. Gagnon will also participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please click here to visit the conference website.
A live audio webcast of the presentation will be available on the IR Calendar page of the Investors section of the Company’s website (www.ceapro.com). A webcast replay will be accessible for 90 days following the live presentation.
About Ceapro Inc.
Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information on Ceapro, please visit the Company’s website at www.ceapro.com.
For more information contact:
Jenene Thomas Communications, LLC
Investor Relations and Corporate Communications Advisor
T (US): +1 (833) 475-8247
Gilles R. Gagnon, M.Sc., MBA
President & CEO
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release
Upcoming Life Sciences Events
- February 2020
- Amsterdam: Pharma & Biotech Patent Litigation
- March 2020
- : Evolution Summit
- Tokyo: BIO Asia International Conference